The stock market is mixed Monday, with the Dow Jones Industrial Average down 0.05%, the Nasdaq up 0.31% and the S&P 500 flat. Today’s winners include a company undergoing a leadership change and a pharmaceutical company reporting positive drug data, while today’s losers include a company which had an article published in a prominent publication about the company’s weak balance sheet and another who is having its accounting practices scrutinized.
These are today’s market winners and losers.
Biggest Winners
Shares of Strategic Hotels & Resorts, Inc. (NYSE: BEE) are up 14.00% to $6.35 on trading volume of 8.9 million shares. Laurence Geller announced Friday that he was stepping down as President and CEO of the company, effective immediately. The 52-week high is $7.01.
Shares of BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) are up 31.62% to $49.24 on trading volume of 8.4 million shares. The company reported positive late-stage drug for its drug to treat Morquio syndrome. Before Monday, the 52-week high was $49.24.
Biggest Loser
Shares of Radian Group Inc. (NYSE: RDN) are down 11.90% to $4.74 on trading volume of 4.7 million shares. Shares declined following an article published by Barron’s regarding a weak balance sheet. The 52-week low is $1.91.
Shares of Ebix Inc. (NASDAQ: EBIX) are down 20.79% to $17.75 on trading volume of 4.2 million shares. Bloomberg reports the company is being investigated by the Securities and Exchange Commission regarding its accounting practices. The 52-week low is $16.17.
Samuel Weigley
Follow him on Twitter: SWeigley
Take This Retirement Quiz To Get Matched With An Advisor Now (Sponsored)
Are you ready for retirement? Planning for retirement can be overwhelming, that’s why it could be a good idea to speak to a fiduciary financial advisor about your goals today.
Start by taking this retirement quiz right here from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes. Smart Asset is now matching over 50,000 people a month.
Click here now to get started.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.